Reviva Announces FDA Alignment on Brilaroxazine Clinical Trials for NDA in Schizophrenia
– FDA acceptance of 4-week global registrational Phase 3 RECOVER-2 study – – Two positive 4-week studies plus a 12-month […]
Atossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast Cancer
SEATTLE, April 15, 2024 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) and Quantum Leap Healthcare […]
CONTEXTLOGIC VOTE UPDATE: Less Than 350,000 Shares Needed to Approve the Proposed Transaction with Qoo10
SAN FRANCISCO, April 15, 2024 (GLOBE NEWSWIRE) — ContextLogic Inc. (d/b/a Wish) (NASDAQ: WISH) (“ContextLogic” or the “Company”) today mailed a […]
TOMI Environmental Solutions to Attend Interphex 2024
FREDERICK, Md., April 15, 2024 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in […]
Longeveron’s CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer’s Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer’s Association International Conference (AAIC)
MIAMI, April 15, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today […]
IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness
NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating therapeutic […]
LiveOne (Nasdaq: LVO) Subsidiary Slacker Radio Hits All Time High Country Music Usage, Helping to Increase Revenue 300% and Driving a Remarkable 800% Increase in Share of Female Country Artists Across Radio Programming
– Management Guides Slacker Radio to $85M and $20M Adjusted EBITA for FY2025; a 4X Revenue Growth and Increase of […]
HeartCore Signs 14th Go IPO Contract
NEW YORK and TOKYO, April 15, 2024 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a […]
iPower to Participate in the Water Tower Research Fireside Chat Series on April 18
RANCHO CUCAMONGA, Calif., April 15, 2024 (GLOBE NEWSWIRE) — iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”), a tech and […]
CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)
BERKELEY HEIGHTS, N.J., April 15, 2024 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and […]
